In tumor types with frequent FADD amplification, such as head and neck cancer, it has been suggested that combined treatment with SMAC mimetics (Birinapant) and radiation may be particularly useful as FADD is key in sensitization to cell death [16]. The gene discussed is FADD; the disease is neoplasm.